Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-11-04 Purchase |
2021-11-08 9:12 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
5,357,143 | $3.5 | $18,750,001 | 3,571,428 (Indirect) |
View |
2021-11-04 Purchase |
2021-11-08 9:06 pm |
Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner |
5,357,143 | $3.5 | $18,750,001 | 3,571,428 (Indirect) |
View |
2020-06-19 Purchase |
2020-06-23 9:38 pm |
Compass Therapeutics Inc. | Sunderland Julie Director |
289,118 | $5 | $1,445,590 | 2,502,025 (Indirect) |
View | |
2020-06-19 Purchase |
2020-06-23 9:38 pm |
Compass Therapeutics Inc. | Schuetz Thomas J. Chief Executive Officer |
97,431 | $5 | $487,155 | 4,525,467 (Direct) |
View | |
2020-06-19 Purchase |
2020-06-23 9:37 pm |
Compass Therapeutics Inc. | Ferneau Philip Director |
314,066 | $5 | $1,570,330 | 400,280 (Indirect) |
View | |
2020-06-19 Purchase |
2020-06-23 9:37 pm |
Compass Therapeutics Inc. | GORDON CARL L Director 10% Owner |
1,455,132 | $5 | $7,275,660 | 12,714,404 (Indirect) |
View | |
2020-06-19 Purchase |
2020-06-23 9:36 pm |
Compass Therapeutics Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner |
1,455,132 | $5 | $7,275,660 | 12,714,404 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-02-18 Option Award |
2022-02-23 5:45 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | SQUINTO STEPHEN P Director |
30,000 | $0 | 30,000 (Direct) |
View |
2022-02-18 Option Award(A) |
2022-02-23 5:30 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | Kalled Susan Chief Scientific Officer |
60,000 | $0 | 60,000 (Direct) |
View |
2022-02-18 Option Award(A) |
2022-02-23 5:30 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
500,000 | $0 | 500,000 (Direct) |
View |
2022-02-18 Option Award(A) |
2022-02-23 5:30 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. Chief Executive Officer |
700,000 | $0 | 700,000 (Direct) |
View |
2022-02-17 Option Award |
2022-02-18 7:13 pm |
N/A 2032-02-16 |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. Chief Executive Officer |
700,000 | $0 | 700,000 (Direct) |
View |
2022-02-17 Option Award |
2022-02-18 7:13 pm |
N/A 2032-02-16 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
500,000 | $0 | 500,000 (Direct) |
View |
2022-02-17 Option Award |
2022-02-18 6:55 pm |
N/A 2032-02-16 |
Compass Therapeutics Inc. | CMPX | Kalled Susan Chief Scientific Officer |
60,000 | $0 | 60,000 (Direct) |
View |
2021-11-16 Option Award |
2021-11-18 7:00 pm |
N/A N/A |
Compass Therapeutics Inc. | Schuetz Thomas J. Chief Executive Officer |
600,000 | $0 | 5,125,467 (Direct) |
View | |
2021-11-16 Option Award |
2021-11-18 7:00 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
600,000 | $0 | 1,113,401 (Direct) |
View |
2021-06-25 Other |
2021-06-29 2:31 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Toledano Miranda Jayne Director |
1,791,549 | $0 | 3,633,098 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 2:31 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Toledano Miranda Jayne Director |
50,000 | $0 | 3,633,098 (Direct) |
View |
Ownership |
2021-06-29 2:30 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Toledano Miranda Jayne Director |
0 | $0 | 0 (Direct) |
View |
2021-05-03 Option Award |
2021-05-05 3:03 pm |
N/A 2031-05-03 |
Compass Therapeutics Inc. | Kalled Susan Chief Scientific Officer |
260,000 | $0 | 260,000 (Direct) |
View | |
2021-02-09 Option Award |
2021-03-01 10:35 am |
N/A 2031-02-09 |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. Chief Executive Officer |
700,000 | $0 | 700,000 (Direct) |
View |
2021-02-09 Option Award |
2021-03-01 10:34 am |
N/A 2031-02-09 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered President & COO |
400,000 | $0 | 400,000 (Direct) |
View |
2020-12-22 Option Award |
2020-12-23 5:00 pm |
N/A 2030-12-22 |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. Chief Executive Officer |
250,000 | $0 | 250,000 (Direct) |
View |
2020-09-10 Option Award |
2020-09-14 8:02 pm |
N/A 2030-09-10 |
Compass Therapeutics Inc. | Kaplan Brett Director |
60,000 | $0 | 60,000 (Direct) |
View | |
2020-08-06 Option Award |
2020-08-10 8:58 pm |
N/A 2030-08-06 |
Compass Therapeutics Inc. | SQUINTO STEPHEN P Director |
30,000 | $0 | 30,000 (Direct) |
View | |
2020-08-06 Option Award |
2020-08-10 8:52 pm |
N/A 2030-08-06 |
Compass Therapeutics Inc. | Bisker-Leib Vered Chief Operating Officer |
600,000 | $0 | 600,000 (Direct) |
View | |
2020-08-06 Option Award |
2020-08-10 8:50 pm |
N/A 2030-08-06 |
Compass Therapeutics Inc. | Schuetz Thomas J. Chief Executive Officer |
500,000 | $0 | 500,000 (Direct) |
View | |
Ownership |
2020-06-29 10:41 am |
N/A N/A |
Compass Therapeutics Inc. | ANDERSON ERRIK 10% Owner |
0 | $0 | 5,290,270 (Direct) |
View | |
Ownership |
2020-06-23 9:36 pm |
N/A N/A |
Compass Therapeutics Inc. | Bisker-Leib Vered Chief Operating Officer |
0 | $0 | 513,401 (Direct) |
View | |
Ownership |
2020-06-23 9:36 pm |
N/A N/A |
Compass Therapeutics Inc. | Schuetz Thomas J. Chief Executive Officer |
0 | $0 | 4,428,036 (Direct) |
View | |
Ownership |
2020-06-23 9:35 pm |
N/A N/A |
Compass Therapeutics Inc. | Ferneau Philip Director |
0 | $0 | 2,435,190 (Indirect) |
View | |
Ownership |
2020-06-23 9:35 pm |
N/A N/A |
Compass Therapeutics Inc. | Sunderland Julie Director |
0 | $0 | 2,212,907 (Indirect) |
View | |
Ownership |
2020-06-23 9:34 pm |
N/A N/A |
Compass Therapeutics Inc. | SQUINTO STEPHEN P Director |
0 | $0 | 34,540 (Direct) |
View | |
Ownership |
2020-06-23 9:33 pm |
N/A N/A |
Compass Therapeutics Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner |
0 | $0 | 11,259,272 (Direct) |
View | |
Ownership |
2020-06-23 9:33 pm |
N/A N/A |
Compass Therapeutics Inc. | GORDON CARL L Director 10% Owner |
0 | $0 | 11,259,272 (Indirect) |
View |